Exchange: STO Sector: Financial Services Industry: Asset Management
-1.14% SEK78.00
America/New_York / 17 mai 2024 @ 11:29
FUNDAMENTALS | |
---|---|
MarketCap: | 4 517.01 mill |
EPS: | 7.00 |
P/E: | 11.14 |
Earnings Date: | May 15, 2024 |
SharesOutstanding: | 57.91 mill |
Avg Daily Volume: | 0.0355 mill |
RATING 2024-05-17 |
---|
B+ |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Neutral | |
Return On Equity: | Sell | |
Return On Asset: | Strong Buy | |
DE: | Strong Sell | |
P/E: | Buy | |
Price To Book: | Neutral |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt | n/a | n/a | n/a | n/a | n/a | n/a |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE 11.14 | sector: PE -60.04 |
PE RATIO: COMPANY / INDUSTRY |
---|
0x |
Company: PE 11.14 | industry: PE -26.91 |
DISCOUNTED CASH FLOW VALUE |
---|
SEK8.42 (-89.21%) SEK-69.58 |
Date: 2024-05-18 |
Expected Trading Range (DAY) |
---|
SEK 76.43 - 79.57 ( +/- 2.01%) |
ATR Model: 14 days |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | SEK78.00 (-1.14% ) |
Volume | 0.0297 mill |
Avg. Vol. | 0.0355 mill |
% of Avg. Vol | 83.49 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Linc AB is a private equity and venture capital firm, specializing in early, mid and late venture investments in pharmaceutical, life-science and med-tech companies, respectively. The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million to SEK 250 million, the first investment often being a relatively small one and the follow-up investments comprising the larger part of the investment. Linc AB is based in Stockholm, Sweden.private eequity and venture capital firm, specializing in early, mid and late venture investments in pharmaceutical, life-science and med-tech companies, respectively. The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million to SEK 250 million, the first investment often being a relatively small one and the follow-up investments comprising the larger part of the investment. Linc AB is based in Stockholm, Sweden.